Fox Chase Cancer Center News

PHILADELPHIA (April 19, 2021) – The Pennsylvania Medical Society (PAMED) released its list of the 2021 Top Physicians Under 40. Six Fox Chase Cancer Center doctors were honored:

PHILADELPHIA (April 16, 2021)—Alexander Kutikov, MD, FACS, chief of the Division of Urology and Urologic Oncology at Fox Chase Cancer Center, co-authored two publications examining important treatment decisions in kidney cancer and illustrating the role of minimally invasive partial nephrectomy—partial removal of the kidney—in the treatment of renal masses, which are abnormal growths on the kidney.

PHILADELPHIA (April 16, 2021)—Colleen H. Tetzlaff, MHS, PA-C, advanced practice clinician in the Department of Hematology/Oncology at Fox Chase Cancer Center, has been recognized as the recipient of the first-ever Sharon Schwartz Award, which is presented by the Recognition and Development Model (RDM) Committee at Fox Chase.

PHILADELPHIA (April 14, 2021) – In a study published today, researchers at Fox Chase Cancer Center announced that they have discovered a novel approach to triggering a type of cancer cell death called ferroptosis that could have therapeutic potential.

PHILADELPHIA (April 9, 2021)— During a poster session at this year’s American Association for Cancer Research (AACR) Annual Meeting Part 1, researchers at Fox Chase Cancer Center will present findings from a recent study on predicting therapy response in locally advanced rectal cancer patients.

PHILADELPHIA (April 9, 2021)— During a poster session at this year’s American Association for Cancer Research (AACR) Annual Meeting Part 1, researchers at Fox Chase Cancer Center will present findings from a recent study on predicting therapy response in locally advanced rectal cancer patients.

PHILADELPHIA (April 8, 2021)—A study from researchers at Fox Chase Cancer Center has shown that while complication rates differ among methods of reconstructive breast surgery, both implants and autologous methods that use a patient’s own tissue are safe options.

PHILADELPHIA (April 7, 2021)—In a recent study, researchers at Fox Chase Cancer Center identified several factors that may accurately predict the presence of malignant cells in pancreatic cancer patients who undergo a peritoneal washing.